The market for tissue microarrays is set to grow at 42% per year from $13 million in 2002 to over $163 million by 2008
Tissue Microarrays: Market Assessment and Opportunities presents a detailed market model and thorough analysis of the technologies and business strategies of 22 leading TMA companies. It is based on extensive primary and secondary research and discusses the background of the main market applications:
- Morphology - Gene Copy Number - Gene Expression - Protein Expression and Localization - Target/ Biomarker Discovery & Validation - Drug Development / Clinical Trials - Assay Development / Quality Control
The report provides in-depth information on the market and size segmented by technology and application. In addition to a detailed market model, Tissue Microarrays : Market Assessment and Opportunities evaluates the strengths and weaknesses of each of the TMA vendors, and assesses both opportunities and threats facing their products & services. The companies most likely to dominate specific market segments, as well as the companies most likely to play key supporting roles in moving technologies forward are identified.
Sample Page:
State of the Market in 2004
Competition
Tissue microarrays as product Competition is high
In addition to the companies mentioned in this report, many academic institutions and pharmaceutical companies obtain tissue microarrays for their use either in house or through collaboration with other institutions. Tissue microarrays as service Competition is low
Some of the commercial tissue array suppliers offer custom arraying services. A few also offer staining and data analysis services. As the use of tissue microarrays for different applications increases, the demand for services will go up. Increased demand of customized services will also grow with the increased use of this technology in clinical trials.
